about the author

Brittany Meiling

editors@endpointsnews.com
Brittany Meiling on LinkedIn

author articles

Amid a bois­ter­ous fundrais­ing week, Bio­Med­Part­ners airs $107M biotech fund

8 years ago
Financing

Watch out En­do: Sor­ren­to is af­ter your $1B+ drug with FDA OK of ZTli­do

8 years ago
Pharma

Scopia snags two board seats at Acor­da fol­low­ing stock pur­chase; BeiGene nabs sec­ond in­di­ca­tion for Revlim­id in Chi­na

8 years ago
News Briefing

Di­al­ing down the tox­ic ef­fects of ra­di­a­tion on can­cer pa­tients, Galera gets break­through sta­tus on Phase IIb da­ta

8 years ago
R&D

Start­up mak­ing Cas9 proxy for gene edit­ing gets $55M to de­vel­op tools/soft­ware

8 years ago
Financing

Haul­ing in a $100M mega-round, gene ther­a­py start­up Gen­er­a­tion Bio builds al­ter­na­tive to po­ten­tial­ly risky vi­ral ...

8 years ago
Financing
Startups

Stock nose­dives for car­dio­vas­cu­lar drug­mak­er Ar­ca fol­low­ing Phase IIb AF fail­ure

8 years ago
R&D

Up­start GeneTx launch­es, go­ing head to head with Ovid on rare An­gel­man syn­drome

8 years ago
Startups

Mer­ck­'s melanoma drug shows ear­ly promise for re­sis­tant can­cers in PhI tri­al

8 years ago
R&D

FDA of­fers quick re­view for Shire's prospec­tive block­buster lanadelum­ab; Big Phar­ma loves big buy­backs

8 years ago
News Briefing

Stem cell co Mesoblast re­ports PhI­II tri­al suc­cess in chil­dren with GVHD

8 years ago
R&D

Is NYC a biotech hub? Gut-brain start­up Kally­ope, equipped with $66M in new mon­ey, says yes

8 years ago
Financing
Startups

Se­nior R&D ex­ec Sue Dil­lon jumps ship at J&J, launch­es mys­tery biotech start­up Aro with Cen­tyrins tech

8 years ago
Startups

Take­da com­mits to a $230M pack­age to seal block­buster neu­ro­log­i­cal R&D deal with Wave Life Sci­ences

8 years ago
R&D
Pharma

Amid buzz around a short sell­er’s FBI vis­it, MiMedx stock craters fol­low­ing in­ter­nal in­ves­ti­ga­tion

8 years ago
Pharma

Roche and Take­da try on Em­u­late’s 'or­gan chip' tech for R&D

8 years ago
R&D
Discovery

Well, that got awk­ward. Arc­turus fires back at ex-CEO Joe Payne

8 years ago
People

Roche pays $1.9B for Ex-Googlers’ tech start­up Flat­iron Health

8 years ago
Startups
Deals

Sil­i­con Val­ley celebs chip in­to $250M round for age-fight­ing start­up Celu­lar­i­ty. Pla­cen­ta-based CAR-Ts on the ...

8 years ago
Startups

Biover­a­tiv inks $100M gene ther­a­py deal with Ox­ford Bio­Med­ica

8 years ago
Pharma
Cell/Gene Tx

Stock slumps for Tel Aviv's Galmed fol­low­ing PhI­Ia NAFLD flop

8 years ago
R&D

What does biotech think about ‘right-to-try'? It might sur­prise you

8 years ago
Pharma

AI start­up BioX­cel Ther­a­peu­tics shoots for $69M IPO with drugs for Alzheimer's, can­cer

8 years ago
Financing

New year, new tax rates. How did the world’s biggest drug­mak­ers fare?

8 years ago
R&D
First page Previous page 891011121314 Next page Last page
A service from the Financial Times